Will Providers Compete With Hubs And Pharma For Drug Discovery Customers?

Here’s hoping this doesn’t rise to the category of grandiloquent theories, but the convergence of two global trends in drug discovery should be considered by business strategists at outsourcing providers as well as pharma sponsors. First, all roads lead to hubs. From Boston to Beijing and Munich to Melbourne, proximity is promise. Second, pharma is reaching into academia and out to startups with a renewed dynamism in their efforts to refill pipelines.

Combine the two – locate pharma assets within life sciences clusters to be closer to academia investigators and start-ups – like Bayer has done in Mission Bay, San Francisco, and drug discovery outsourcing providers might get squeezed out of new market opportunities. What is at stake? Potentially a lot…

via Will Providers Compete With Hubs And Pharma For Drug Discovery Customers?